These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38734217)

  • 1. Characterising the blood-stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum.
    Barber BE; Webster R; Potter AJ; Llewellyn S; Sahai N; Leelasena I; Mathison S; Kuritz K; Flynn J; Chalon S; Marrast AC; Gobeau N; Moehrle JJ
    Int J Antimicrob Agents; 2024 Jul; 64(1):107196. PubMed ID: 38734217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
    Barber BE; Abd-Rahman AN; Webster R; Potter AJ; Llewellyn S; Marquart L; Sahai N; Leelasena I; Birrell GW; Edstein MD; Shanks GD; Wesche D; Moehrle JJ; McCarthy JS
    Clin Infect Dis; 2023 Jun; 76(11):1919-1927. PubMed ID: 36795050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers.
    McCarthy JS; Rückle T; Elliott SL; Ballard E; Collins KA; Marquart L; Griffin P; Chalon S; Möhrle JJ
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Hine P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.
    McCarthy JS; Rückle T; Djeriou E; Cantalloube C; Ter-Minassian D; Baker M; O'Rourke P; Griffin P; Marquart L; Hooft van Huijsduijnen R; Möhrle JJ
    Malar J; 2016 Sep; 15(1):469. PubMed ID: 27624471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study.
    McCarthy JS; Yalkinoglu Ö; Odedra A; Webster R; Oeuvray C; Tappert A; Bezuidenhout D; Giddins MJ; Dhingra SK; Fidock DA; Marquart L; Webb L; Yin X; Khandelwal A; Bagchus WM
    Lancet Infect Dis; 2021 Dec; 21(12):1713-1724. PubMed ID: 34715032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
    Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
    Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
    Bukirwa H; Unnikrishnan B; Kramer CV; Sinclair D; Nair S; Tharyan P
    Cochrane Database Syst Rev; 2014 Mar; (3):CD006404. PubMed ID: 24596021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatus.
    Kawai S; Kano S; Chang C; Suzuki M
    Am J Trop Med Hyg; 1996 Aug; 55(2):223-9. PubMed ID: 8780465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa.
    Ringwald P; Bickii J; Basco L
    Lancet; 1996 Jan; 347(8993):24-8. PubMed ID: 8531545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the Antimalarial Activity of Cipargamin in Healthy Volunteers Experimentally Infected with Blood-Stage Plasmodium falciparum.
    McCarthy JS; Abd-Rahman AN; Collins KA; Marquart L; Griffin P; Kümmel A; Fuchs A; Winnips C; Mishra V; Csermak-Renner K; Jain JP; Gandhi P
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33199389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with
    Collins KA; Rückle T; Elliott S; Marquart L; Ballard E; Chalon S; Griffin P; Möhrle JJ; McCarthy JS
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30858218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Bayesian hierarchical pharmacokinetic-pharmacodynamic model for predicting parasitological outcomes in Phase 2 studies of new antimalarial drugs.
    Tully MK; Dini S; Flegg JA; McCarthy JS; Price DJ; Simpson JA
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0086324. PubMed ID: 39136464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.
    Rottmann M; Jonat B; Gumpp C; Dhingra SK; Giddins MJ; Yin X; Badolo L; Greco B; Fidock DA; Oeuvray C; Spangenberg T
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32041711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study.
    Barber BE; Fernandez M; Patel HB; Barcelo C; Woolley SD; Patel H; Llewellyn S; Abd-Rahman AN; Sharma S; Jain M; Ghoghari A; Di Resta I; Fuchs A; Deni I; Yeo T; Mok S; Fidock DA; Chalon S; Möhrle JJ; Parmar D; McCarthy JS; Kansagra K
    Lancet Infect Dis; 2022 Jun; 22(6):879-890. PubMed ID: 35247321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects.
    Krause A; Dingemanse J; Mathis A; Marquart L; Möhrle JJ; McCarthy JS
    Br J Clin Pharmacol; 2016 Aug; 82(2):412-21. PubMed ID: 27062080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.